rs139179263
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 4P and 3B. PM1PM2BP4_ModerateBS1_Supporting
The ENST00000360215.3(LHFPL5):c.476G>A(p.Arg159His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,614,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R159C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000360215.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHFPL5 | NM_182548.4 | c.476G>A | p.Arg159His | missense_variant | 2/4 | ENST00000360215.3 | NP_872354.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHFPL5 | ENST00000360215.3 | c.476G>A | p.Arg159His | missense_variant | 2/4 | 1 | NM_182548.4 | ENSP00000353346 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000532 AC: 81AN: 152180Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000247 AC: 62AN: 251412Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135896
GnomAD4 exome AF: 0.000102 AC: 149AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.0000976 AC XY: 71AN XY: 727248
GnomAD4 genome AF: 0.000532 AC: 81AN: 152298Hom.: 0 Cov.: 31 AF XY: 0.000403 AC XY: 30AN XY: 74470
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 12, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 159 of the LHFPL5 protein (p.Arg159His). This variant is present in population databases (rs139179263, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with LHFPL5-related conditions. ClinVar contains an entry for this variant (Variation ID: 163857). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | LHFPL5: PP3 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 19, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Arg159His var iant in LHFPL5 has been reported in 1 individual with hearing loss by our labora tory (LMM unpublished data), but has been identified in 0.17% of African chromos omes by the genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.or g; dbSNP rs139179263). This variant has also been reported in ClinVar (Variation ID 163857). Computational prediction tools and conservation analyses suggest th at this variant may impact the protein, though this information is not predictiv e enough to determine pathogenicity. In summary, while the clinical significance of the p.Arg159His variant is uncertain, population data suggest that it is mor e likely to be benign. - |
LHFPL5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 31, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at